BEAM logo

Beam Therapeutics Inc. (BEAM) EBITDA

Annual EBITDA:

-$393.64M-$237.17M(-151.57%)
December 31, 2024

Summary

  • As of today, BEAM annual EBITDA is -$393.64 million, with the most recent change of -$237.17 million (-151.57%) on December 31, 2024.
  • During the last 3 years, BEAM annual EBITDA has fallen by -$17.62 million (-4.69%).
  • BEAM annual EBITDA is now -4902.45% below its all-time high of -$7.87 million, reached on December 31, 2017.

Performance

BEAM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

Quarterly EBITDA:

-$121.25M-$6.64M(-5.79%)
September 30, 2025

Summary

  • As of today, BEAM quarterly EBITDA is -$121.25 million, with the most recent change of -$6.64 million (-5.79%) on September 30, 2025.
  • Over the past year, BEAM quarterly EBITDA has dropped by -$20.22 million (-20.02%).
  • BEAM quarterly EBITDA is now -187.72% below its all-time high of $138.22 million, reached on December 31, 2023.

Performance

BEAM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

TTM EBITDA:

-$444.22M-$20.22M(-4.77%)
September 30, 2025

Summary

  • As of today, BEAM TTM EBITDA is -$444.22 million, with the most recent change of -$20.22 million (-4.77%) on September 30, 2025.
  • Over the past year, BEAM TTM EBITDA has dropped by -$283.39 million (-176.20%).
  • BEAM TTM EBITDA is now -3418.82% below its all-time high of -$12.62 million, reached on September 30, 2018.

Performance

BEAM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BEAM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-151.6%-20.0%-176.2%
3Y3 Years-4.7%-41.5%-52.4%
5Y5 Years-464.4%-246.2%-304.1%

BEAM EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-151.6%at low-187.7%at low-197.4%at low
5Y5-Year-464.4%at low-187.7%+38.3%-304.1%at low
All-TimeAll-Time-4902.4%at low-187.7%+38.3%-3418.8%at low

BEAM EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$121.25M(-5.8%)
-$444.22M(-4.8%)
Jun 2025
-
-$114.61M(-0.8%)
-$423.99M(-3.7%)
Mar 2025
-
-$113.76M(-20.3%)
-$408.70M(-3.8%)
Dec 2024
-$393.64M(-151.6%)
-$94.59M(+6.4%)
-$393.64M(-144.8%)
Sep 2024
-
-$101.03M(-1.7%)
-$160.83M(-0.1%)
Jun 2024
-
-$99.32M(-0.6%)
-$160.59M(-2.9%)
Mar 2024
-
-$98.70M(-171.4%)
-$156.13M(-4.5%)
Dec 2023
-$156.47M(+50.5%)
$138.22M(+237.1%)
-$149.36M(+59.7%)
Sep 2023
-
-$100.79M(-6.3%)
-$370.37M(-4.3%)
Jun 2023
-
-$94.86M(-3.2%)
-$355.27M(-5.5%)
Mar 2023
-
-$91.93M(-11.0%)
-$336.86M(-6.6%)
Dec 2022
-$315.90M(+16.0%)
-$82.80M(+3.4%)
-$315.90M(-8.3%)
Sep 2022
-
-$85.69M(-12.1%)
-$291.57M(-7.3%)
Jun 2022
-
-$76.45M(-7.7%)
-$271.69M(-8.5%)
Mar 2022
-
-$70.97M(-21.4%)
-$250.35M(+33.4%)
DateAnnualQuarterlyTTM
Dec 2021
-$376.02M(-205.0%)
-$58.47M(+11.2%)
-$376.00M(-5.8%)
Sep 2021
-
-$65.81M(-19.4%)
-$355.39M(-9.5%)
Jun 2021
-
-$55.10M(+72.0%)
-$324.60M(-10.6%)
Mar 2021
-
-$196.61M(-419.4%)
-$293.60M(-138.1%)
Dec 2020
-$123.29M(-76.8%)
-$37.85M(-8.1%)
-$123.29M(-12.2%)
Sep 2020
-
-$35.02M(-45.3%)
-$109.92M(-20.0%)
Jun 2020
-
-$24.11M(+8.3%)
-$91.57M(-9.2%)
Mar 2020
-
-$26.30M(-7.4%)
-$83.88M(-20.3%)
Dec 2019
-$69.75M(-54.7%)
-$24.48M(-46.8%)
-$69.75M(-19.6%)
Sep 2019
-
-$16.68M(-1.5%)
-$58.29M(-7.5%)
Jun 2019
-
-$16.42M(-35.0%)
-$54.24M(-43.4%)
Mar 2019
-
-$12.17M(+6.6%)
-$37.82M(-47.4%)
Dec 2018
-$45.09M(-473.0%)
-$13.03M(-3.2%)
-$25.65M(-103.2%)
Sep 2018
-
-$12.62M
-$12.62M
Dec 2017
-$7.87M
-
-

FAQ

  • What is Beam Therapeutics Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. annual EBITDA year-on-year change?
  • What is Beam Therapeutics Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. quarterly EBITDA year-on-year change?
  • What is Beam Therapeutics Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. TTM EBITDA year-on-year change?

What is Beam Therapeutics Inc. annual EBITDA?

The current annual EBITDA of BEAM is -$393.64M

What is the all-time high annual EBITDA for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high annual EBITDA is -$7.87M

What is Beam Therapeutics Inc. annual EBITDA year-on-year change?

Over the past year, BEAM annual EBITDA has changed by -$237.17M (-151.57%)

What is Beam Therapeutics Inc. quarterly EBITDA?

The current quarterly EBITDA of BEAM is -$121.25M

What is the all-time high quarterly EBITDA for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high quarterly EBITDA is $138.22M

What is Beam Therapeutics Inc. quarterly EBITDA year-on-year change?

Over the past year, BEAM quarterly EBITDA has changed by -$20.22M (-20.02%)

What is Beam Therapeutics Inc. TTM EBITDA?

The current TTM EBITDA of BEAM is -$444.22M

What is the all-time high TTM EBITDA for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high TTM EBITDA is -$12.62M

What is Beam Therapeutics Inc. TTM EBITDA year-on-year change?

Over the past year, BEAM TTM EBITDA has changed by -$283.39M (-176.20%)
On this page